High sensitivity C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation
摘要Background C-reactive protein (CRP) is one of the acute phase proteins that increase during systemic inflammation.It's been suggested that testing CRP levels in the blood may be an additional way to assess cardiovascular disease risk.A more sensitive CRP test, called a highly sensitive C-reactive protein (hs-CRP) assay, is available to determine heart disease risk.However, the association between CRP and stent thrombosis after drug-eluting stent implantation has not been defined.So we designed this study to investigate in a follow-up study whether high-sensitivity C-reactive protein(hs-CRP) predicts coronary heart disease (CHD) events and stent thrombosis in subjects undergone drug-eluting stent implantation.
更多相关知识
- 浏览0
- 被引0
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文